The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Biomanufacturing World Summit 2022

November 13 – 15, 2022

Join us at BMWS 2022 this year in Carlsbad. Thermo Fisher Scientific’s pharma services group will be exhibiting at Booth #11.

As a proud sponsor of this event, we welcome you to join our lunch round table on Monday, November 14th from 12:55 pm – 1:55 pm PST to discuss “Strategies for navigating CDMOs as a small biotech and the value of early engagement” with Larry Pitcher, our Senior Director and General Manager, Microbial Manufacturing Services, mRNA and Advanced Therapies.

Event details 

Location: 
The Omni La Costa Resort & Spa
2100 Costa Del Mar Road
Carlsbad, CA 92009

 

Booth number: Booth #11

Date and time: November 13-15, 2022

Format: Live

Also on Monday, Joao Paulo Mattos, Director, Global Process Validation and CMC lead, Biologics, will be presenting “Pushing the efficient frontier of biomanufacturing to speed up drug development and enhance productivity” at 11:40 am PST in Room 1. Join us for this exciting topic.

On Tuesday, November 15th, Pouria Motevalian, Director of Process Development, will moderate a Lunch-and-Learn Roundtable from 12:55 pm – 1:55 pm PST. Join the conversation on “Bringing the Digital Revolution to Gene Therapy Process Development and Scale-Up”.

Our experts will also be available to meet with you. Click on the link below to set up meetings to discuss how we can assist with your processes.

We look forward to meeting you there.

Live sessions

Monday, November 14th:

12:55 pm – 1:55 pm PST

Larry Pitcher,
Senior Director and General Manager,
Microbial Manufacturing Services, mRNA, Advanced Therapies

Strategies for navigating CDMOs as a small biotech and the value of early engagement

 

Larry Pitcher

About Larry Pitcher
Operations and business leader with experience running manufacturing sites across different geographies and regulated industries. Currently, Larry is serving as the GM for Thermo Fisher’s rapidly growing Plasmid DNA CDMO business with multi-site responsibilities. Previously, he has held GM roles for Thermo Fisher’s viral vector manufacturing CDMO business at both the Alachua, FL and Cambridge, MA locations.

Before joining the CGT industry with Thermo Fisher Scientific, via Brammer Bio, Larry spent over a decade with RTI Surgical in the Medical Device, HCTP, and pharmaceutical space leading sites in Europe and the US. Larry holds a B.S. in Engineering and MBA.

Monday, November 14th:

11:40 am PST, Room 1.

Joao Paulo Mattos,
Director,
Global Process Validation and CMC lead,
Biologics

Pushing the efficient frontier of biomanufacturing to speed up drug development and enhance productivity

 

Joao Paulo Mattos

About Joao Paulo Mattos
Joao Paulo Mattos is Director of Global Process Validation and CMC Lead at Thermo Fisher Scientific and has responsibility for process validation and CMC strategy for late stage and commercial programs across six drug substance manufacturing and development sites located globally.

Joao Paulo has previously held roles in manufacturing sciences, process validation, and technology transfer. Prior to joining Thermo Fisher Joao Paulo worked for Bluebird bio, TESARO, and Bristol-Myers Squibb. He holds a B.S. in Chemical-Biological Engineering from MIT, and a Ph.D in Bioengineering from Rice University.

Tuesday, November 15th:

12:55 pm – 1:55 pm PST

Pouria Motevalian,
Director of Process Development

Bringing the Digital Revolution to Gene Therapy Process Development and Scale-Up

 

Pauria Motevalian

About Pouria Motevalian
As Director of Process Development, Pouria Motevalian leads process characterization, optimization and scale up for viral vectors at Thermo Fisher Scientific. Additionally, he oversees process modeling/simulation and knowledge management activities. Prior to joining Thermo Fisher Scientific, Pouria led early and late-stage process development of biologics, conjugate/mRNA vaccines, at Pfizer. Furthermore, he played an integral part in deploying new technologies focused on digital enablement in bioprocess research and development.

Pouria received his Ph.D. in Chemical Engineering with minor in Computational Science from the Pennsylvania State University. He has been an active contributor to the professional and scientific community in ACS, AIChE and AAPS.

 

Continuing education for the pharma industry 

 

Follow us on social for event updates